GSK PLC closed 26.98% short of its 52-week high of £18.24, which the company reached on May 16th.

GSK PLC closed 30.68% below its 52-week high of £18.24, which the company achieved on May 16th.

CureVac (CVAC) has reported its fourth quarter 2024 financial results, generating mixed reactions from investors as the company balances ...

NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential ...

Fear returned to the world’s stock markets today after Donald Trump’s swingeing new “Liberation Day” tariffs came into force.

European and Asian stocks rocketed higher on Thursday after Donald Trump paused his “reciprocal” tariffs, but Wall Street and ...

Pharmaceutical imports became the latest target for President Donald Trump’s tariffs, sending FTSE 100 drugmakers stock into ...

Stock markets rocketed higher around the world following Donald Trump’s decision to pause his “reciprocal” tariffs – but Wall ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The FTSE 100 has plunged today after Donald Trump enforced a whopping 104% tariff on Chinese imports. The latest levy came ...

European stock markets closed mostly lower in Friday trading as the Stoxx Europe 600 was off 0.10%, Germany's DAX dropped 0.92%, the FTSE 100 in London was up 0.64%, France's CAC 40 fell 0.30%, and ...

GSK bought into the EOS-448 programme last year in a deal orchestrated by its chief scientific officer Hal Barron, who is leaving to join biotech startup Altos at the beginning of August.